Abstract:BACKGROUND AND OBJECTIVE:Liver disease is a multifactorial complex disease with high global prevalence and poor long-term clinical efficacy and liver disease patients with different comorbidities often incorporate multiple phenotypes in the clinic. Thus, there is a pressing need to improve understanding of the complexity of clinical liver population to help gain more accurate disease subtypes for personalized treatment.METHODS:Individualized treatment of the traditional Chinese medicine (TCM) provides a theoretical basis to the study of personalized classification of complex diseases. Utilizing the TCM clinical electronic medical records (EMRs) of 6475 liver inpatient cases, we built a liver disease comorbidity network (LDCN) to show the complicated associations between liver diseases and their comorbidities, and then constructed a patient similarity network with shared symptoms (PSN). Finally, we identified liver patient subgroups using community detection methods and performed enrichment analyses to find both distinct clinical and molecular characteristics (with the phenotype-genotype associations and interactome networks) of these patient subgroups.RESULTS:From the comorbidity network, we found that clinical liver patients have a wide range of disease comorbidities, in which the basic liver diseases (e.g. hepatitis b, decompensated liver cirrhosis), and the common chronic diseases (e.g. hypertension, type 2 diabetes), have high degree of disease comorbidities. In addition, we identified 303 patient modules (representing the liver patient subgroups) from the PSN, in which the top 6 modules with large number of cases include 51.68% of the whole cases and 251 modules contain only 10 or fewer cases, which indicates the manifestation diversity of liver diseases. Finally, we found that the patient subgroups actually have distinct symptom phenotypes, disease comorbidity characteristics and their underlying molecular pathways, which could be used for understanding the novel disease subtypes of liver conditions. For example, three patient subgroups, namely Module 6 (M6, n = 638), M2 (n = 623) and M1 (n = 488) were associated to common chronic liver disease conditions (hepatitis, cirrhosis, hepatocellular carcinoma). Meanwhile, patient subgroups of M30 (n = 36) and M36 (n = 37) were mostly related to acute gastroenteritis and upper respiratory infection, respectively, which reflected the individual comorbidity characteristics of liver subgroups. Furthermore, we identified the distinct genes and pathways of patient subgroups and the basic liver diseases (hepatitis b and cirrhosis), respectively. The high degree of overlapping pathways between them (e.g. M36 with 93.33% shared enriched pathways) indicates the underlying molecular network mechanisms of each patient subgroup.CONCLUSIONS:Our results demonstrate the utility and comprehensiveness of disease classification study based on community detection of patient network using shared TCM symptom phenotypes and it can be used to other more complex diseases.

Community Detector on Symptom Networks with Applications to Fatty Liver Disease

Bridging Fatty Liver Disease and Traditional Chinese Medicine: A Complex Network Approach.

Symptom-based Network Classification Identifies Distinct Clinical Subgroups of Liver Diseases with Common Molecular Pathways.

Multisystem Health Comorbidity Networks of Nonalcoholic Fatty Liver Disease: Phenome-Wide Mendelian Randomization and Disease-Trajectory Analyses

A Novel Model for Predicting Fatty Liver Disease by Means of an Artificial Neural Network

An Improved Fuzziness Based Random Vector Functional Link Network for Liver Disease Detection

Probabilistic Scatter Plots for Visualizing Carbohydrate and Lipid Metabolism States in Non-Alcoholic Fatty Liver Disease

A novel liver cancer diagnosis method based on patient similarity network and DenseGCN

Clinical data mining on network of symptom and index and correlation of tongue-pulse data in fatigue population

Machine Learning Reveals Serum Glycopatterns as Potential Biomarkers for the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD)

Identification of potential feature genes in non-alcoholic fatty liver disease using bioinformatics analysis and machine learning strategies

Federated-Learning-based Hierarchical Diagnosis of Liver Fibrosis

Prediction of Fatty Liver Disease in a Chinese Population Using Machine-Learning Algorithms

Feature Selection and Syndrome Prediction for Liver Cirrhosis in Traditional Chinese Medicine

LMFLS: A new fast local multi-factor node scoring and label selection-based algorithm for community detection

Screening of co-pathogenic genes of non-alcoholic fatty liver disease and hepatocellular carcinoma

Characterization of signature trends across the spectrum of non-alcoholic fatty liver disease using deep learning method

Integrated network analysis of symptom clusters across disease conditions

Clinical Study on Data Mining of Tcm Zheng in Chronic Hepatitis B

Electronic Medical Records for Discovery Research in Nonalcoholic Fatty Liver Disease

Symptom Selection Of Inquiry Diagnosis Data For Coronary Heart Disease In Traditional Chinese Medicine By Using Social Network Techniques